Skip to content
Boost Up Blog – Lifestyle
Author:
Grace Therapeutics, Inc.
Grace Therapeutics Announces $10 Million Private Placement
August 4, 2026
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
July 28, 2026
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
June 18, 2026
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
April 23, 2026
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
April 14, 2026
DPC Dash Ltd Announces Full Year 2025 Financial Results
March 25, 2026
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
March 19, 2026